CINCINNATI (WKRC) - A common and inexpensive vaccine has shown to successfully treat Type 1 diabetes patients, restoring their blood sugar levels to near-normal.
The vaccine has been used for tuberculosis but, used recently as an experimental treatment to fight diabetes, it's shown to potentially be a more effective option than insulin treatment, according to a report in the Boston Herald.
It works by eliminating tissue-attacking cells and increasing production of T cells, which can prevent harmful autoimmune reaction.
The research was published in the journal njp Vaccines.
It was a small sample size, but three people with diabetes received two doses of the vaccine starting in 2007.
The project expanded following promising signs of effectiveness as six more patients were given the vaccine up to five years ago. Then 111 more were given the treatment recently.
Those who received the treatment saw a drop in hemoglobin A1c from an average of 7.26 to 6.18 — just above the normal levels, which are generally below 6.
While very promising, more studies and research are needed before this becomes an approved method of battling diabetes in the medical community.